Dupixent approved in China as the first-ever biologic medicine for patients with COPD Approval follows EU approval of Dupixent for…
AI Revolutionizes Life Sciences: Transforming Drug Discovery, Personalized Medicine, and Patient Outcome. BCC Research Study Projects a 27.9% CAGR, with…
NORTH CANTON, Ohio, Sept. 26, 2024 /PRNewswire/ -- The Collegiate Inventors Competition®, an annual competition that has rewarded innovations, discoveries…
Hub has already attracted more than 1,000 members – and is quickly expandingPlume has served more than 35,000 trans adults…
TEL AVIV, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Holdco Nuvo Group D.G Ltd (“Nuvo”), a pioneer in remote pregnancy…
The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra's…
CHICAGO, IL / ACCESSWIRE / September 25, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…
DENVER, Sept. 25, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary…
Istaroxime significantly improved primary endpoint of the systolic blood pressure profile over six hours and showed significant improvements in many…
– Completion of nonclinical safety and toxicity studies, Phase 1 clinical trial design and established Maximum Recommended Starting Dose –…